Associated Papers
Voltage-gated potassium channels as a potential therapeutic target for the treatment of neurological and psychiatric disorders.
Faulkner IE et al.
Frontiers in Cellular Neuroscience, 2024
Case Report: Targeted treatment by fluoxetine/norfluoxetine of a KCNC2 variant causing developmental and epileptic encephalopathy.
Li P et al.
Frontiers in Pharmacology, 2024
Pharmacological approaches in drug-resistant pediatric epilepsies caused by pathogenic variants in potassium channel genes.
Filareto I et al.
Frontiers in Cellular Neuroscience, 2024
A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine.
Ambrosino P et al.
Epilepsia, 2023
Cryo-EM structure of the human Kv3.1 channel reveals gating control by the cytoplasmic T1 domain.
Chi G et al.
Nature Communications, 2022
Select a paper to view details